Dena M. Attallah
Background: The quality of patient care is a universal concern among healthcare managers, policymakers and consumers. In order to benchmark and improve patient outcomes and demonstrate the impact of high-quality care provided by ambulatory chemotherapy services (ACSs), it is important to develop patient-reported nurse-sensitive indicators, specific to chemotherapy-related symptoms and experiences of supportive care. This study builds on previous work by Armes et al. (2014) who developed the Patient-Reported Chemotherapy Indicators of Symptoms and Experience (PR-CISE).
Aims: This study aims to explore a range of methodological and feasibility issues that relate to the development and implementation of Nurse-Sensitive Outcome indicators (NSOIs) and associated tools in the Kingdom of Saudi Arabia (KSA). It also aims to establish whether variability exists in Nurse-sensitive Outcomes (NSOs) amongst ambulatory chemotherapy units in the KSA.
Methods: A feasibility study employed a descriptive, crosssectional survey with two preparation stages. In Stage I, instrument items were developed. In Stage II, the feasibility of delivering the protocol was evaluated and the questionnaire piloted.
Results: The pilot testing of the recruitment, research tools, and data collection process was useful in providing the groundwork. The cross-sectional survey confirmed that survey processes were efficient. Significant differences were observed in the distribution of the severity of symptoms between ACSs in six out of seven studied symptoms.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi